TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Angel Medical Systems, Inc.
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL IMPLANTABLE CARDIAC MONITORS MARKET, BY INDICATION
6.1. Overview
6.2. Cardiac Arrhythmias
6.3. Atrial Fibrillation
6.4. Epilepsy and Unexplained Falls
7. GLOBAL IMPLANTABLE CARDIAC MONITORS MARKET, BY END-USER
7.1. Overview
7.2. Ambulatory Surgical Centers (Ascs)
7.3. Hospitals and Clinics
7.4. Home Settings
8. GLOBAL IMPLANTABLE CARDIAC MONITORS MARKET, BY REGION
8.1. Overview
8.1. North America
8.1.1. US
8.1.2. Canada
8.2. Europe
8.2.1. Germany
8.2.2. France
8.2.3. UK
8.2.4. Italy
8.2.5. Spain
8.2.6. Rest of Europe
8.3. Asia-Pacific
8.3.1. China
8.3.2. India
8.3.3. Japan
8.3.4. South Korea
8.3.5. Australia
8.3.6. Rest of Asia-Pacific
8.4. Rest of the World
8.4.1. Middle East
8.4.2. Africa
8.4.3. Latin America
9. COMPETITIVE LANDSCAPE
9.1. Overview
9.2. Competitive Analysis
9.3. Market Share Analysis
9.4. Major Growth Strategy in the Global Implantable Cardiac Monitors Market,
9.5. Competitive Benchmarking
9.6. Leading Players in Terms of Number of Developments in the Global Implantable Cardiac Monitors Market,
9.7. Key developments and Growth Strategies
9.7.1. New Product Launch/Service Deployment
9.7.2. Merger & Acquisitions
9.7.3. Joint Ventures
9.8. Major Players Financial Matrix
9.8.1. Sales & Operating Income, 2023
9.8.2. Major Players R&D Expenditure. 2023
10. COMPANY PROFILES
10.1. Medtronic plc
10.1.1. Company Overview
10.1.2. Financial Overview
10.1.3. Products Offered
10.1.4. Key Developments
10.1.5. SWOT Analysis
10.1.6. Key Strategies
10.2. Abbott Laboratories
10.2.1. Company Overview
10.2.2. Financial Overview
10.2.3. Products Offered
10.2.4. Key Developments
10.2.5. SWOT Analysis
10.2.6. Key Strategies
10.3. Boston Scientific Corporation
10.3.1. Company Overview
10.3.2. Financial Overview
10.3.3. Products Offered
10.3.4. Key Developments
10.3.5. SWOT Analysis
10.3.6. Key Strategies
10.4. BIOTRONIK SE & Co. KG
10.4.1. Company Overview
10.4.2. Financial Overview
10.4.3. Products Offered
10.4.4. Key Developments
10.4.5. SWOT Analysis
10.4.6. Key Strategies
10.5. MicroPort Scientific Corporation
10.5.1. Company Overview
10.5.2. Financial Overview
10.5.3. Products Offered
10.5.4. Key Developments
10.5.5. SWOT Analysis
10.5.6. Key Strategies
10.6. LivaNova PLC
10.6.1. Company Overview
10.6.2. Financial Overview
10.6.3. Products Offered
10.6.4. Key Developments
10.6.5. SWOT Analysis
10.6.6. Key Strategies
10.7. Angel Medical Systems, Inc.
10.7.1. Company Overview
10.7.2. Financial Overview
10.7.3. Products Offered
10.7.4. Key Developments
10.7.5. SWOT Analysis
10.7.6. Key Strategies
10.8. Medico S.p.A.
10.8.1. Company Overview
10.8.2. Financial Overview
10.8.3. Products Offered
10.8.4. Key Developments
10.8.5. SWOT Analysis
10.8.6. Key Strategies
10.9. INFOBIONIC
10.9.1. Company Overview
10.9.2. Financial Overview
10.9.3. Products Offered
10.9.4. Key Developments
10.9.5. SWOT Analysis
10.9.6. Key Strategies
10.10. BIOTELEMETRY, INC.
10.10.1. Company Overview
10.10.2. Financial Overview
10.10.3. Products Offered
10.10.4. Key Developments
10.10.5. SWOT Analysis
10.10.6. Key Strategies
11. APPENDIX
11.1. References
11.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL IMPLANTABLE CARDIAC MONITORS MARKET, SYNOPSIS, 2019-2032
TABLE 2 GLOBAL IMPLANTABLE CARDIAC MONITORS MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)
TABLE 3 GLOBAL IMPLANTABLE CARDIAC MONITORS MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 4 GLOBAL IMPLANTABLE CARDIAC MONITORS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 5 NORTH AMERICA: IMPLANTABLE CARDIAC MONITORS MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 6 NORTH AMERICA: IMPLANTABLE CARDIAC MONITORS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 7 US: IMPLANTABLE CARDIAC MONITORS MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 8 US: IMPLANTABLE CARDIAC MONITORS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 9 CANADA: IMPLANTABLE CARDIAC MONITORS MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 10 CANADA: IMPLANTABLE CARDIAC MONITORS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 1 EUROPE: IMPLANTABLE CARDIAC MONITORS MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 2 EUROPE: IMPLANTABLE CARDIAC MONITORS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 3 GERMANY: IMPLANTABLE CARDIAC MONITORS MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 4 GERMANY: IMPLANTABLE CARDIAC MONITORS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 5 FRANCE: IMPLANTABLE CARDIAC MONITORS MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 6 FRANCE: IMPLANTABLE CARDIAC MONITORS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 7 ITALY: IMPLANTABLE CARDIAC MONITORS MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 8 ITALY: IMPLANTABLE CARDIAC MONITORS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 9 SPAIN: IMPLANTABLE CARDIAC MONITORS MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 10 SPAIN: IMPLANTABLE CARDIAC MONITORS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 11 UK: IMPLANTABLE CARDIAC MONITORS MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 12 UK: IMPLANTABLE CARDIAC MONITORS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 13 REST OF EUROPE: IMPLANTABLE CARDIAC MONITORS MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 14 REST OF EUROPE: IMPLANTABLE CARDIAC MONITORS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 15 ASIA-PACIFIC: IMPLANTABLE CARDIAC MONITORS MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 16 ASIA-PACIFIC: IMPLANTABLE CARDIAC MONITORS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 17 JAPAN: IMPLANTABLE CARDIAC MONITORS MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 18 JAPAN: IMPLANTABLE CARDIAC MONITORS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 19 CHINA: IMPLANTABLE CARDIAC MONITORS MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 20 CHINA: IMPLANTABLE CARDIAC MONITORS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 21 INDIA: IMPLANTABLE CARDIAC MONITORS MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 22 INDIA: IMPLANTABLE CARDIAC MONITORS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 23 AUSTRALIA: IMPLANTABLE CARDIAC MONITORS MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 24 AUSTRALIA: IMPLANTABLE CARDIAC MONITORS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 25 SOUTH KOREA: IMPLANTABLE CARDIAC MONITORS MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 26 SOUTH KOREA: IMPLANTABLE CARDIAC MONITORS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 27 REST OF ASIA-PACIFIC: IMPLANTABLE CARDIAC MONITORS MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 28 REST OF ASIA-PACIFIC: IMPLANTABLE CARDIAC MONITORS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 29 REST OF THE WORLD: IMPLANTABLE CARDIAC MONITORS MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 30 REST OF THE WORLD: IMPLANTABLE CARDIAC MONITORS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 31 MIDDLE EAST: IMPLANTABLE CARDIAC MONITORS MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 32 MIDDLE EAST: IMPLANTABLE CARDIAC MONITORS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 33 AFRICA: IMPLANTABLE CARDIAC MONITORS MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 34 AFRICA: IMPLANTABLE CARDIAC MONITORS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 35 LATIN AMERICA: IMPLANTABLE CARDIAC MONITORS MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 36 LATIN AMERICA: IMPLANTABLE CARDIAC MONITORS MARKET, BY END-USER, 2019-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL IMPLANTABLE CARDIAC MONITORS MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL IMPLANTABLE CARDIAC MONITORS MARKET
FIGURE 4 GLOBAL IMPLANTABLE CARDIAC MONITORS MARKET, SHARE (%), BY INDICATION, 2023
FIGURE 5 GLOBAL IMPLANTABLE CARDIAC MONITORS MARKET, SHARE (%), BY END-USER, 2023
FIGURE 6 GLOBAL IMPLANTABLE CARDIAC MONITORS MARKET, SHARE (%), BY REGION, 2023
FIGURE 7 NORTH AMERICA: IMPLANTABLE CARDIAC MONITORS MARKET, SHARE (%), BY REGION, 2023
FIGURE 8 EUROPE: IMPLANTABLE CARDIAC MONITORS MARKET, SHARE (%), BY REGION, 2023
FIGURE 9 ASIA-PACIFIC: IMPLANTABLE CARDIAC MONITORS MARKET, SHARE (%), BY REGION, 2023
FIGURE 10 REST OF THE WORLD: IMPLANTABLE CARDIAC MONITORS MARKET, SHARE (%), BY REGION, 2023
FIGURE 11 GLOBAL IMPLANTABLE CARDIAC MONITORS MARKET: COMPANY SHARE ANALYSIS, 2023 (%)
FIGURE 12 MEDTRONIC PLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 13 MEDTRONIC PLC: SWOT ANALYSIS
FIGURE 14 ABBOTT LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 15 ABBOTT LABORATORIES: SWOT ANALYSIS
FIGURE 16 BOSTON SCIENTIFIC CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 BOSTON SCIENTIFIC CORPORATION: SWOT ANALYSIS
FIGURE 18 BIOTRONIK SE & CO. KG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 BIOTRONIK SE & CO. KG: SWOT ANALYSIS
FIGURE 20 MICROPORT SCIENTIFIC CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 MICROPORT SCIENTIFIC CORPORATION: SWOT ANALYSIS
FIGURE 22 LIVANOVA PLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 LIVANOVA PLC: SWOT ANALYSIS
FIGURE 24 ANGEL MEDICAL SYSTEMS, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 ANGEL MEDICAL SYSTEMS, INC.: SWOT ANALYSIS
FIGURE 26 MEDICO S.P.A.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 MEDICO S.P.A.: SWOT ANALYSIS
FIGURE 28 INFOBIONIC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 INFOBIONIC: SWOT ANALYSIS
FIGURE 30 BIOTELEMETRY, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 BIOTELEMETRY, INC.: SWOT ANALYSIS